Immunity, microbiota and kidney disease
Crossref DOI link: https://doi.org/10.1038/s41581-019-0118-7
Published Online: 2019-02-22
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Knauf, Felix
Brewer, J. Richard
Flavell, Richard A. https://orcid.org/0000-0003-4461-0778
Text and Data Mining valid from 2019-02-22
Version of Record valid from 2019-02-22
Article History
First Online: 22 February 2019
Competing interests
: R.A.F. is a scientific consultant to GlaxoSmithKline and Zie Labs and a founder, shareholder and advisor to SMOC Therapeutics Inc. The other authors declare no competing interests.